EUVIMEDEUVIMED entdecken
Crossref

Gastrointestinal Stromal Tumors: Update and Therapeutic Strategies

A CHETIBI, M OUALID, R. GHEMIT, R. BELOUZ, I BOUDIS, M SAIDANI

Avicenna Medical Research · 29.09.2023 · 2 (3) · 84-89

DOI: 10.34118/amr.v2i3.3518 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Avicenna Medical Research, online erschienen am 29.09.2023. Verfasst von A CHETIBI und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AbstractGastrointestinal Stromal Tumors (GISTs) represent a significant clinical challenge due to their resistance to conventional chemotherapy. This study aims to provide an update on the clinical, morphological, pathological, and therapeutic aspects of GISTs treated at our institution over an 11-year period. We highlight the efficacy of Imatinib as a targeted therapy and emphasize the importance of complete surgical resection. Additionally, we present a case of concomitant gastric adenocarcinoma and duodenal GIST, underscoring the need for comprehensive clinical evaluation in these cases.

Zitieren

APA

CHETIBI, A., OUALID, M., GHEMIT, R., BELOUZ, R., BOUDIS, I., & SAIDANI, M. (2023). Gastrointestinal Stromal Tumors: Update and Therapeutic Strategies. Avicenna Medical Research, 2(3), 84-89. https://doi.org/10.34118/amr.v2i3.3518

Vancouver

CHETIBI A, OUALID M, GHEMIT R, BELOUZ R, BOUDIS I, SAIDANI M. Gastrointestinal Stromal Tumors: Update and Therapeutic Strategies. Avicenna Medical Research. 2023;2(3):84-89. doi:10.34118/amr.v2i3.3518

BibTeX
@article{CHETIBI2023,
  author = {CHETIBI, A and OUALID, M and GHEMIT, R. and BELOUZ, R. and BOUDIS, I and SAIDANI, M},
  title = {Gastrointestinal Stromal Tumors: Update and Therapeutic Strategies},
  journal = {Avicenna Medical Research},
  year = {2023},
  volume = {2},
  number = {3},
  pages = {84--89},
  doi = {10.34118/amr.v2i3.3518}
}
Kostenlos starten →